Mathias Baedeker
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
2025 FDA approvals: volume maintained, but value remains below average.
Journal: Nature reviews. Drug discovery
Published: January 20, 2026
2024 FDA approvals exceed average number but have lower sales projections.
Journal: Nature reviews. Drug discovery
Published: January 17, 2025
2023 FDA approvals: unprecedented volume at moderate value.
Journal: Nature reviews. Drug discovery
Published: January 17, 2024
2022 FDA approval number dips: a COVID-19 hangover?
Journal: Nature reviews. Drug discovery
Published: January 13, 2023
2021 FDA approvals: value driven by COVID-19 vaccines.
Journal: Nature reviews. Drug discovery
Published: January 18, 2022
2020 FDA approvals: momentum kept despite COVID-19, but value falls.
Journal: Nature reviews. Drug discovery
Published: January 16, 2021
Value of 2019 FDA approvals: back to the recent average.
Journal: Nature reviews. Drug discovery
Published: February 06, 2020
2018 FDA approvals hit all time high - but average value slips again.
Journal: Nature reviews. Drug discovery
Published: February 03, 2019
Market watch: 2017 FDA drug approvals: number rebounds but average value slips.
Journal: Nature reviews. Drug discovery
Published: January 20, 2018
Occlusion in the Flow of New Drugs for Cardiovascular Disease.
Journal: Clinical pharmacology and therapeutics
Published: February 20, 2017
Market watch: Value of 2016 FDA drug approvals: reversion to the mean?
Journal: Nature reviews. Drug discovery
Published: February 03, 2017
Last Updated: 09/26/2026